Ilomedin

Iloprost trometamol, the active ingredient in Ilomedin, is a prostacyclin analog presented as an intravenous solution for use in adult patients. It is employed to treat pulmonary arterial hypertension and to promote healing of digital ulcers associated with systemic sclerosis. The drug acts by activating prostacyclin (IP) receptors, causing vasodilation and inhibition of platelet aggregation, thereby improving pulmonary blood flow.

GNH USA supplies Ilomedin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and clinical use.

Ilomedin, a prostacyclin analog, is used in the management of pulmonary vascular disease and related complications.

- Pulmonary arterial hypertension: improves exercise capacity and reduces pulmonary vascular resistance. - Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces formation of new ulcers. - Pulmonary hypertension related to connective‑tissue disease: helps lower pulmonary artery pressure and supports right‑ventricular function. - Right‑heart failure secondary to PAH: decreases afterload on the right ventricle, aiding cardiac output.

Ilomedin may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: warmth and redness of the skin. - Nausea: occasional upset stomach. - Hypotension: mild drop in blood pressure.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring intervention. - Bleeding: increased risk of hemorrhage, especially with anticoagulants. - Pulmonary edema: fluid accumulation in the lungs.

When using Ilomedin, several precautions should be observed to ensure patient safety.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution; observe liver enzymes. - Bleeding risk: avoid concomitant use with strong anticoagulants unless medically justified. - Pregnancy: limited data; prescribe only if benefits outweigh potential risks. - Hypotension: monitor blood pressure during initiation and dose titration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ilomedin can interact with other medicines; awareness of the interaction level helps guide clinical decisions.

Major Interactions (Avoid): - Nitrates (e.g., nitroglycerin): additive vasodilation may cause severe hypotension. - Anticoagulants (e.g., warfarin, heparin): increased risk of bleeding.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive effect. - Epoprostenol: combined prostacyclin therapy can amplify vasodilatory response. - Nonsteroidal anti‑inflammatory drugs: may affect renal clearance of iloprost.